newsfilter
← Latest News
ACCESS Newswire·

Relief Therapeutics Expands Its Board of Directors with the Appointment of Michelle Lock

Industry Executive Brings Nearly 30 Years of Biopharmaceutical Sales and Commercial ExpertiseGENEVA, SWITZERLAND / ACCESSWIRE / February 2, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company